Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial. Wermke M, Araujo DM, Chatterjee M, Tsimberidou AM, et al. Nat Med 2025;31:2365-2374.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wermke M, Araujo DM, Chatterjee M, Tsimberidou AM, et al. Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial. Nat Med 2025;31:2365-2374.
PMID: 40205198